These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The potential use of viral genomic markers in estimating the neurovirulence of oral poliomyelitis vaccine (OPV): regulatory aspects. Fenyves A. Dev Biol Stand; 1993; 78():157-9. PubMed ID: 8388826 [No Abstract] [Full Text] [Related]
4. Changing poliovirus vaccine policy can be controversial at best. Faden H. Adv Pediatr Infect Dis; 1997; 13():305-32. PubMed ID: 9544317 [No Abstract] [Full Text] [Related]
5. Studies on new attenuated strains of type III live poliomyelitis vaccine. II. Field trials of Zhong III2 virus. Chin Med J (Engl); 1980 Sep; 93(9):591-8. PubMed ID: 6253237 [No Abstract] [Full Text] [Related]
8. Attenuation and reversion of the Sabin vaccine strains of poliovirus. Minor PD. Dev Biol Stand; 1993 Sep; 78():17-26. PubMed ID: 8388828 [Abstract] [Full Text] [Related]
18. [On an epidemic outbreak of poliomyelitis, type 3, in the Voivode County of Poznań in 1968]. Walter T. Zentralbl Bakteriol Orig; 1969 Jan; 211(2):162-6. PubMed ID: 4318358 [No Abstract] [Full Text] [Related]